No Detail Found!

A pilot study of efficacy and safety of Plantago lanceolata and Primula veris, in the treatment of the common cold

Author(s)
Oliva Alfonso Isabel Internal Medicine. Ph.D. student at the University of Pharmacy of Barcelona, Spain
Monleón Getino Antonio Department. Biology Faculty University of Barcelona, Spain.
Rada Fernadez de Jauregui Diego Department. University of the Basque Country, Spain.
Oteiza Larrechea Laura Family and Community Medicine, Osakidetza, Basque Government Health Department, Spain
Rodriguez Gomez Sandra Family and Community Medicine, Osakidetza, Basque Government Health Department, Spain
Garromendiola Garay Jon Kepa Family and Community Medicine, Osakidetza, Basque Government Health Department, Spain
Villa Basterretxea Maite Family and Community Nursing, Osakidetza, Basque Government Health Department, Spain
Madrigal Hormaechea Marisol Family and Community Nursing, Osakidetza, Basque Government Health Department, Spain
Jaio Senra Iraide Family and Community Nursing, Osakidetza, Basque Government Health Department, Spain
del Otero Sanz Laura Preventive Medicine and Public Health. Melilla Government Delegation
Martin Villodre Joan Department, University of Pharmacy of Barcelona, Spain.
Abstract
The ongoing coronavirus disease (COVID-19) pandemic has raised the need for new therapies to treat respiratory infections. A bibliographic review based mainly on the databases of the European medication agency (E.M.A) and the Department of Environment and Territorial Policy of the Basque Government (Spain) was carried out. From both databases, it was observed that 14 plant species of the 408 reviewed plants (3%) are approved for medicinal use at European level and that their use, coincides with the most common reasons for consultation in Primary Care. One of these pathologies (common cold) and 2 medicinal plants (Plantago lanceolata and Primula veris) have been selected for the present study. We will determine the efficacy and safety of the two plant species using one randomized multicenter open clinical trial. In the clinical trials, three treatment groups will run in parallel; two treatment groups with medicinal plants and another group with conventional treatment. The of the clinical trial will be: To objectify the therapeutic effects of the medicinal plants using parameters of usual clinical practice in primary care, to evaluate the side effects and the safety of the use of medicinal plants and to rationalize the mechanism of action of the possible benefits.
Publication Details
Page(s) 1-7
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
Plantago lanceolata, Common cold, Primary care, Primula veris, Medicinal Plants, Acute Respiratory Infections
References
Al Mussaed E. Transfusion .2018 .Therapy: an overview. Journal of Advanced Pharmacy Education & Research| Oct-Dec, 8(4) : .
Zohair GA,Amer MM,EL-shemy A,Bosila MA,Elbayoumi KM . .Diagnosis and Molecular Identification of Virulent Infectious Bursal Disease in Naturally Infected Broiler Chickens. 2017 Oct, 1(5) : 29-34.
Nazer MR,Rafiee-Alavi SE .2018 .Investigating Occupational Infections in Hospital Staff. International Journal of Pharmaceutical and Phytopharmacological Research, 8(4) : 23-7.
Villar ,Territorial Y Política .2010 .. Servicio Central de Publicaciones del Gobierno Vasco, : .
. .. planta=1 21, : .
. .. 2013 Oct, 1 : 99-107.
Research Phytotherapy .1998 .An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. , 12(S1) : S33-4.
Kraft K. Therapeutisches .1997 .Profil eines SpitzwegerichkrautFluidextraktes bei akuten respiratorischen Erkrankungen im Kindesund Erwachsenenalter. InPhytopharmaka III, : 199-209.
Abdin M. . .Possible role for Plantago lanceolata in the treatment of HIV infection?. 2006 Jun, 1(275) : 92-4.
Kernan MR,Amarquaye A,Chen JL,Chan J,Sesin DF,Parkinson N,Ye ZJ,Barrett M,Bales C,Stoddart CA,Sloan B . .Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea. Journal of Natural Products. 1998 May, 22(5) : 564-70.
Chang IM . .Antiviral activity of aucubin against hepatitis B virus replication. Phytotherapy Research: An International Journal Devoted to Medical and Scientific Research on Plants and Plant Products, 11(3) : 189-92.
Haznagy .1970 .A. Recent results with plantaginis folium (Plantain leaves). Herba Hung, 9(2) : 57-63.
. .. , : .
. .. planta=1, 25 : 2.
Buechi S. Antivirale Saponine: Pharmakologische Und Klinische Untersuchungen. Deutsche .1996 .. , 136(2) : .
Chibanguza G,März R,Sterner W. Zur .1984 .Wirksamkeit und Toxizität eines pflanzlichen Sekretolytikums und seiner Einzeldrogen. Arzneimittel-Forschung, 34(1) : 32-6.
Gruenwald J,Graubaum HJ,Busch R . .Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. Arzneimittelforschung, 55(11) : 669-76.
0

Citations

0

Downloads

13

Views